Cleared Abbreviated

K071573 - RUGALIFT, MODEL# V.2.1

K071573 is an FDA 510(k) clearance for RUGALIFT, manufactured by Fatrotek S.R.L.. The device is a Class 2 Neurology device with product code NFO cleared through the Abbreviated 510(k) pathway after a 550-day FDA review.

K071573 · Fatrotek S.R.L. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2008
Decision
550d
Days
Class 2
Risk

K071573 is an FDA 510(k) clearance for the RUGALIFT, MODEL# V.2.1. Classified as Stimulator, Transcutaneous Electrical, Aesthetic Purposes (product code NFO), Class II - Special Controls.

Submitted by Fatrotek S.R.L. (Auvernier, CH). The FDA issued a Cleared decision on December 9, 2008 after a review of 550 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Fatrotek S.R.L. devices

FDA 510(k) Submission Details - K071573

510(k) Number K071573 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 2007
Decision Date December 09, 2008
Days to Decision 550 days
Submission Type Abbreviated
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
402d slower than avg
Panel avg: 148d · This submission: 550d
Pathway characteristics
Standards-based clearance path.

NFO Device Classification - Class 2, Special Controls

Product Code NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.